165 related articles for article (PubMed ID: 170219)
21. Genetics of resistance to infection with Salmonella typhimurium in mice.
Plant J; Glynn AA
J Infect Dis; 1976 Jan; 133(1):72-8. PubMed ID: 1107437
[TBL] [Abstract][Full Text] [Related]
22. Moloney sarcoma virus-induced tumors in athymic (nude) mice: growth pattern and antibody responses.
Davis S
J Natl Cancer Inst; 1975 Mar; 54(3):793-4. PubMed ID: 164570
[TBL] [Abstract][Full Text] [Related]
23. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV.
Coppola MA; Green WR; Rich RF
Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627
[TBL] [Abstract][Full Text] [Related]
24. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation.
Jones DB; Moore M
Br J Cancer; 1974 Jan; 29(1):21-30. PubMed ID: 4820943
[TBL] [Abstract][Full Text] [Related]
25. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
26. [The sensitivity of embryonal cell cultures from rats and mice of different lines the transformation-destructive effect of mouse sarcoma virus].
Argirova RM; Zakharova LG; Al'shteĭn AD
Vopr Virusol; 1973; 18(1):54-9. PubMed ID: 4365038
[No Abstract] [Full Text] [Related]
27. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.
Hilgers J; Haverman J; Nusse R; van Blitterswijk WJ; Cleton FJ; Hageman PC; van Nie P; Calafat J
J Natl Cancer Inst; 1975 Jun; 54(6):1323-33. PubMed ID: 166186
[TBL] [Abstract][Full Text] [Related]
28. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
29. Transformation of horse skin cells by type-C sarcoma viruses.
Rhim JS; Ro HS; Kim EB; Gilden RV; Huebner RJ
Int J Cancer; 1975 Feb; 15(2):171-9. PubMed ID: 165152
[TBL] [Abstract][Full Text] [Related]
30. Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.
Sato H; Boyse EA; Aoki T; Iritani C; Old LJ
J Exp Med; 1973 Sep; 138(3):593-606. PubMed ID: 4727915
[TBL] [Abstract][Full Text] [Related]
31. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
Green WR
J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
[TBL] [Abstract][Full Text] [Related]
32. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
Ishikawa H; Kubota E; Saito K
J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
[TBL] [Abstract][Full Text] [Related]
33. Moloney murine leukemia virus-induced tumors: recombinant proviruses in active chromatin regions.
van der Putten H; Quint W; Verma IM; Berns A
Nucleic Acids Res; 1982 Jan; 10(2):577-92. PubMed ID: 6278422
[TBL] [Abstract][Full Text] [Related]
34. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
Klein E; Klein G
Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
[No Abstract] [Full Text] [Related]
35. Host control of endogenous murine leukemia virus gene expression: concentrations of viral proteins in high and low leukemia mouse strains.
Strand M; Lilly F; August JT
Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3682-6. PubMed ID: 4372631
[TBL] [Abstract][Full Text] [Related]
36. Relationship of infectious murine leukemia virus and virus-related antigens in genetic crosses between AKR and the Fv-1 compatible strain C57L.
Ikeda H; Rowe WP; Boyse EA; Stockert E; Sato H; Jacobs S
J Exp Med; 1976 Jan; 143(1):32-46. PubMed ID: 172587
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of virus production and antigenicity detected in cell clones derived from a "nonproducer" neoplasm induced by Moloney murine sarcoma virus.
Law LW; Chang KS; Nakata K
J Natl Cancer Inst; 1974 Feb; 52(2):437-43. PubMed ID: 4361177
[No Abstract] [Full Text] [Related]
38. Protective effect of murine sarcoma virus-superinfected mouse tumor cells against outgrowth of corresponding noninfected tumor.
Kuzumaki N; Fenyö EM; Klein E; Klein G
Transplantation; 1978 Nov; 26(5):304-7. PubMed ID: 705875
[TBL] [Abstract][Full Text] [Related]
39. Two dominant host resistance genes to pre-B lymphoma in wild-derived inbred mouse strain MSM/Ms.
Pataer A; Kamoto T; Lu LM; Yamada Y; Hiai H
Cancer Res; 1996 Aug; 56(16):3716-20. PubMed ID: 8706013
[TBL] [Abstract][Full Text] [Related]
40. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
